Your Partner for Next Generation In-Silico Drug Discovery
Inte:Ligand supports scientists worldwide with innovative approaches for drug discovery research using computer-aided design solutions. Molecular designers in the pharmaceutical, cosmetic, and other life science industries use our solutions to design and identify novel bioactive molecules. We develop the most innovative and user friendly modeling software platforms and provide expert consulting to inspire the innovative process of designing molecules, filtering ideas, and de-risking candidates.
Our computational platforms empower clients to:
- Streamline Discovery: Fast-track lead structure identification and optimization.
- Mitigate Risk: Analyze safety and potential side-effects to reduce dropout rates.
- Lower Costs & Accelerate Time-to-Market: Use data-driven insights to drastically reduce preclinical development expenses.
Partner with us to accelerate your research and bring your innovations to life.
Find out more about our products and services.
Innovative User-Friendly Software to Empower Research
Software Solutions
Inte:Ligand delivers a unified ecosystem of next-generation software engineered to turn complex chemical data into strategic discovery decisions. By bridging advanced 3D-structural intelligence with predictive safety profiling, our solutions empower researchers to confidently prioritize leads, map target engagement, and de-risk pipelines early in the discovery life cycle.
- Ultra-High-Throughput Modeling, LigandScout XT Next Generation offers:
- Gigascale accurate screening
- AI generative molecule building
- MD and dynamic water mapping
- LigandScout 4.5 Gold Standard remains the industry benchmark for precise 3D-pharmacophore engineering.
- Structural Intelligence repositories: The IL PharmDB provides a premium, manually curated collection of over 9,000 models, uniquely optimized for target searching and decoding phenotypic screening results.
- Strategic Safety & Design: IL NeuroDeRisk Toolbox delivers advanced predictive profiling to eliminate early-stage neurotoxic risks, while our IL eToxPlus, and IL CYP450 collections deliver the early safety data required to drive critical, risk-mitigating decisions that shape tomorrow's medical breakthroughs.
Find out more about our software platforms:
Expert Consulting Services to Inspire the Innovative Process
Contract Research Services
Inte:Ligand is specialized in advancing your drug discovery journey. Our expertise lies in more than 30 years experience in providing consulting services for the life science industries.
- Pharmaceutical
- Biotechs and SMEs
- MedChem CROs
- Cosmetic Industry
- Food and Flavorings
- Animal Health
- Crop Protection
We guide you through the Hit to Lead and Lead Optimization phases, ensuring that your promising compounds are refined for maximum efficacy and safety. Our unique advanced Pharmacophore Technology, enables
- Identification of essential molecular features crucial for datamining and effective drug design.
- Integration with physics based, AI generative and machine learning approaches tailored to your specific research needs.
- Unique cutting-edge Virtual Screening capabilities to streamline the identification of potential drug candidates.
Partner with us to accelerate your research and bring your innovations to life.
Find out more about our services.
🆕 LigandScout XT Next Generation
All new, yet familiar
Redefining Drug Discovery with AI, Scale & Dynamics
LigandScout XT expands the gold-standard LigandScout 4.5 platform with revolutionary new modalities — from billion-compound virtual screening and covalent inhibitor profiling to AI-driven molecule generation and full molecular dynamics integration.
Ultra-Large VS - Covalent Screening - AI Generative Builder - MD Simulations - Water Thermodynamics
Next Generation Molecular Design
All that with extreme high performance.
We call that our next generation!
10⁹
Compounds screened
Ultra-Large Scale Virtual Screening
Screen up to one billion compounds against pharmacophore models. Seamless integration with ultra-large chemical libraries for unprecedented hit-finding power.
GIGASCALE
360°
Covalent inhibitor discovery
Covalent Ligand Virtual Screening
Model warhead reactivity and covalent binding modes. Identify irreversible inhibitor candidates within our pharmacophore screening workflows.
COVALENT
AI
De novo design
AI Generative Molecule Builder
De novo molecule generation conditioned on pharmacophore models. AI proposes novel scaffolds fitting your 3D feature requirements and ADMET constraints.
AI · DE NOVO
MD Simulations
Dynamics
Easy-to-Set-Up
Launch GPU-accelerated molecular dynamics from LigandScout. Automated force-field assignment and trajectory analysis — one seamless workflow.
MD · GPU
MD+H₂O
MD simulations with water thermodynamics
Water Thermodynamic Mapping
Identify displaceable vs. conserved water sites from MD trajectories using free-energy scores to guide ligand design decisions.
ΔGSOLV
Find out more about LigandScout XT!
LigandScout 4.5 Expert
The Gold Standard for Advanced 3D-Pharmacophore Technology
LigandScout 4.5 Expert is the most user-friendly, fully integrated molecular design suite, powered by our award winning 3D-pharmacophore modeling and high-speed virtual screening technology. As a highly validated platform licensed in 88 countries, it has been cited in more than 3,900 research articles to accelerate drug discovery and provide actionable structural insights. LigandScout 4.5 features apo-pharmacophores, convenient docking and the power of LigandScout Remote, allowing for seamless execution on high-performance computing (HPC) clusters and cloud environments like AWS. This ensures that even the most demanding virtual screening and library generation tasks are handled with unprecedented speed and scalability, directly from your desktop interface.
Find out more about LigandScout 4.5 Expert!
🆕 IL NeuroDeRisk In Silico Toolbox
Neurotoxicity De-Risking in Preclinical Drug Discovery
The NeuroDeRisk In Silico Toolbox, developed in the framework of the NeuroDeRisk Consortium provides a mechanistically grounded ecosystem for proactive neurotoxicity risk assessment. Built on the LigandScout next-generation pharmacophore technology, the toolbox targets three critical domains: Seizure Liability (addressing ion channels like GABA-A and NMDA), Psychological/Psychiatric Effects (covering dopaminergic and serotonergic systems), and Peripheral Neuropathies (identifying mitochondrial and axonal damage). Unlike "black-box" AI, our models deliver interpretable, actionable structural insights, allowing medicinal chemists to mitigate liabilities at the earliest stages of design. Validated against industry-curated datasets, it is the premier resource for de-risking pipelines and improving the next generation medicines.
Find out more about the IL NeuroDeRisk Toolbox!
IL PharmDB
3D Pharmacophore Collection
Target Activity and Selectivity Profiling, Toxicity and Metabolism Flagging
Inte:Ligand’s Pharmacophore Database (IL PharmDB) is a premium, meticulously curated collection of 3D-chemical feature-based pharmacophores built on years of expert modeling experience. Manually assembled and rigorously quality-checked, this powerful database serves as an essential engine for parallel virtual screening, compound activity profiling, and drug repurposing. It is uniquely optimized to translate phenotypic screening results into actionable target hypotheses through reverse screening. The IL PharmDB provides researchers with a robust toolkit for translating complex structural data into clear, actionable hypotheses, driving faster and more confident decision-making in compound prioritization and pipeline de-risking.
Find out more about the IL PharmDB!
ilib:diverse
High Quality Virtual Compound Libraries
iLib:Diverse is a comprehensive, fragment-based combinatorial chemistry platform designed to streamline the creation of high-quality virtual compound libraries. It utilizes intelligent algorithms to help researchers build, filter, and refine virtual collections with a focus on chemical diversity and drug-likeness.
Find out more about ilib:diverse!